naltrexone targets Oprd1
Evidence from:
primary |
all sources
Evidence (2 sources)
Naltrexone is a non-selective antagonist of mu, kappa, and delta opioid receptors
confidence: 0.98
Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.
(2012)
PMID:22954510
cited
delta receptor blockade was lower (about 21%) but also highly variable
confidence: 0.90